Article
Home negative pressure ventilation: Report of 20 years of experience in patients with neuromuscular disease

https://doi.org/10.1016/0003-9993(85)90157-1Get rights and content

Abstract

Twenty years of experience using negative pressure devices (NPD) at home to ventilate 40 patients with neuromuscular disease is presented. The purpose of the study was to determine the costs, complications, and clinical outcome of this form of respiratory support, and to ascertain the reasons for failure to institute effective negative pressure ventilation (NPV) in nine patients. Emerson tank respirators, used mainly to rest respiratory muscles at night, and intermittent postitive pressure breathing machines were used by 98% of patients at an average equipment cost of $2,700 annually. Patients in whom NPV was initiated on an elective rather than emergent basis saved an average of $12,000 during their initial hospitalization. Life table analysis shows a five-year survival of 76%, and a 10-year survival of 61%. Complications were minor and occurred at an average rate of less than one per year per patient at home on NPV. Failure to achieve satisfactory NPV in nine patients was associated with age (six patients were younger than 3 years of age), or severe thoracocervical scoliosis, which prevented proper fitting of the NPD. For reasons of safety, economy, and quality of life, NPV at home is the preferred treatment for patients having neuromuscular disease who need respiratory assistance.

References (19)

There are more references available in the full text version of this article.

Cited by (75)

  • The evolving course of neuromuscular disease

    2023, Pulmonary Assessment and Management of Patients with Pediatric Neuromuscular Disease
  • Noninvasive Ventilation: Concepts and Practice

    2011, Pediatric Critical Care: Expert Consult Premium Edition
  • Sleep Problems in Children with Respiratory Disorders

    2008, Sleep Medicine Clinics
    Citation Excerpt :

    Sleep-related breathing disorders are common in Duchenne muscular dystrophy (DMD) with OSAS common in the first decade and hypoventilation developing in the second decade for reasons outlined previously.118 There is a long history of treating children with neuromuscular disorders including spinal muscular atrophy, myopathies, and dystrophies who develop chronic hypercapneic respiratory failure with a variety of different forms of noninvasive ventilation (NIV) or tracheostomy-positive pressure ventilation at home with improved survival and quality of life.80,119 The evidence supporting treatment of nocturnal hypoventilation before the development of diurnal respiratory failure is limited.

  • Non-invasive positive ventilation in the treatment of sleep-related breathing disorders

    2007, Sleep Medicine
    Citation Excerpt :

    Depending on the medical centers, the three main methods for delivering tidal volume were used: intermittent negative pressure ventilation [2–4], intermittent positive pressure ventilation (IPPV) by tracheostomy [4,5] or IPPV by mouthpiece [6,7]. These experiences have progressively encouraged a few clinicians to use therapeutic approaches such as these to chronically ventilate other types of respiratory insufficiency such as seen in Duchenne dystrophy, chest-wall deformities and even lung diseases [4,5,7–9]. Nevertheless, in the early 1980s, despite positive results, clinicians were reluctant to use these techniques, considering them too invasive (tracheostomy) or cumbersome or of limited efficacy to ventilate patients with impaired mechanics (negative pressure) [10].

  • Chronic Respiratory Failure

    2006, Kendig's Disorders of the Respiratory Tract in Children
View all citing articles on Scopus
View full text